Berkeley, CA, United States of America

Sean David Gallaher

This inventor holds 2 USPTO granted patents. Top assignee: University of California. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sean David Gallaher. Retrieved from https://idiyas.com/inventor/sean-david-gallaher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2021-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Sean D. Gallaher

Introduction

Sean D. Gallaher is an accomplished inventor based in Los Angeles, CA. He has made significant contributions to the field of biotechnology, particularly in the area of astaxanthin biosynthesis. His work has implications for various industries, including pharmaceuticals and nutrition.

Latest Patents

Sean D. Gallaher holds a patent related to "Genes involved in astaxanthin biosynthesis." This patent encompasses nucleic acid, host cell, and polypeptide compositions encoded by the unicellular green alga. It also details methods for creating these compositions and their applications in producing astaxanthin.

Career Highlights

Gallaher is affiliated with the University of California, where he continues to advance research in his field. His innovative work has garnered attention and recognition within the scientific community.

Collaborations

Some of his notable coworkers include Melissa S. Roth and Krishna K. Niyogi. Their collaborative efforts contribute to the ongoing research and development in biotechnology.

Conclusion

Sean D. Gallaher exemplifies the spirit of innovation in biotechnology through his research and patent contributions. His work on astaxanthin biosynthesis showcases the potential for advancements in health and nutrition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…